Articles dans des revues avec comité de lecture (60)
  1. 33. Meraviglia, S., Eberl, M., Vermijlen, D., Todaro, M., Buccheri, S., Cicero, G., La Mendola, C., Guggino, G., D'Asaro, M., Orlando, V., Scarpa, F., Roberts, A., Caccamo, N., Stassi, G., Dieli, F., & Hayday, A. C. (2010). In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clinical and experimental immunology, 161(2), 290-297. doi:10.1111/j.1365-2249.2010.04167.x
  2. 34. Vermijlen, D., Brouwer, M., donner, C., Liesnard, C., Tackoen, M., Van Rysselberge, M., Twite, N., Goldman, M., Marchant, A., & Willems, F. (2010). Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. The Journal of experimental medicine, 207(4), 807-821. doi:10.1084/jem.20090348
  3. 35. Van Coppernolle, S., Verstichel, G., Timmermans, F., Velghe, I., Vermijlen, D., De Smedt, M., Leclercq, G., Plum, J., Taghon, T., Vandekerckhove, B., & Kerre, T. (2009). Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells. The Journal of immunology, 183(8), 4859-4870. doi:10.4049/jimmunol.0900714
  4. 36. Dieli, F., Vermijlen, D., Fulfaro, F., Caccamo, N., Meraviglia, S., Cicero, G., Roberts, A., Buccheri, S., D'Asaro, M., Gebbia, N., Salerno, A., Eberl, M., & Hayday, A. C. (2007). Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer research, 67(15), 7450-7457. doi:10.1158/0008-5472.CAN-07-0199
  5. 37. Vermijlen, D., Ellis, P., Langford, C., Klein, A., Engel, R., Willimann, K., Jomaa, H., Hayday, A. C., & Eberl, M. (2007). Distinct cytokine-driven responses of activated blood gammadelta T cells: insights into unconventional T cell pleiotropy. The Journal of immunology, 178(7), 4304-4314.
  6. 38. Vermijlen, D., Ellis, P., Langford, C., Eberl, M., Hayday, A. C., & Roberts, A. (2007). IGSF4 expression by unconventional T cells: A role in T-T interaction? Immunology, 120(Supplément S1), 66. doi:10.1111/j.1365-2567.2007.02571.x
  7. 39. Hayday, A. C., Strid, J., Vermijlen, D., & Girardi, M. (2006). The biology and clinical application of tumor surveillance by unconventional T cells. Breast cancer research and treatment, 100, 2.
  8. 40. Vermijlen, D., Eberl, M., Ellis, P., Langford, C., & Hayday, A. C. (2005). Gene expression analysis of human gamma-delta T cells. Immunology, 116(Supplément S1), 14. doi:10.1111/j.1365-2567.2005.02287.x
  9. 41. Pennington, D. J., Vermijlen, D., Wise, E. L., Clarke, S. L., Tigelaar, R. E., & Hayday, A. C. (2005). The integration of conventional and unconventional T cells that characterizes cell-mediated responses. Advances in immunology, 87, 27-59. doi:10.1016/S0065-2776(05)87002-6
  10. 42. Timmers, M., Vekemans, K., Vermijlen, D., Asosingh, K., Kuppen, P. J., Bouwens, L., Wisse, E., & Braet, F. (2004). Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. International journal of cancer, 112(5), 793-802. doi:10.1002/ijc.20481
  11. 43. Vermijlen, D., Seynaeve, C., Luo, D., Kruhøffer, M., Eizirik, D. L., Ørntoft, T., & Wisse, E. (2004). High-density oligonucleotide array analysis reveals extensive differences between freshly isolated blood and hepatic natural killer cells. European Journal of Immunology, 34(9), 2529-2540. doi:10.1002/eji.200324712
  12. 44. Van Hemelrijck, A., Vermijlen, D., Hachimi-Idrissi, S., Sarre, S., Ebinger, G., & Michotte, Y. (2003). Effect of resuscitative mild hypothermia on glutamate and dopamine release, apoptosis and ischaemic brain damage in the endothelin-1 rat model for focal cerebral ischaemia. Journal of neurochemistry, 87(1), 66-75. doi:10.1046/j.1471-4159.2003.01977.x
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>